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Background:  There  are  conﬂicting  ﬁndings  regarding  the  impact  of  residential  mobility  on immunisation
status.  Our  aim was  to  determine  whether  there  was any  association  between  residential  mobility  and
take up  of  immunisations  and  whether  they  were  delayed  in  administration.
Methods:  We  carried  out a  cohort  analysis  of children  born  in Wales,  UK.  Uptake  and  time  of immunisation
were  collected  electronically.  We  deﬁned  frequent  movers  as those  who  had  moved:  2 or more  times  in
the  period  prior  to  the  ﬁnal  scheduled  on-time  date  (4 months)  for 5  in 1 vaccinations;  and  3  or  more
times  in  the  period  prior  to the  ﬁnal  scheduled  on-time  date  (12  months)  for MMR,  pneumococcal  and
meningitis  C vaccinations.  We  deﬁned  immunisations  due  at 2–4  months  delayed  if  they  had  not  been
given  by age  1; and  those  due  at  12–13  months  as  delayed  if they  had  not  been  given by  age  2.
Results:  Uptake  rates  of  routine  immunisations  and  whether  they  were  given  within  the  speciﬁed  time-
frame  were  high  for both  groups.  There  was  no  increased  risk  (odds  ratios (95% conﬁdence  intervals)
between  frequent  movers  compared  to non-movers  for the  uptake  of:  primary  MMR  1.08  (0.88–1.32);
booster  Meningitis  C  1.65  (0.93–2.92);  booster  pneumococcal  1.60  (0.59–4.31);  primary  5 in 1  1.28
(0.92–1.78);  and  timeliness:  primary  MMR  0.92  (0.79–1.07);  booster  Meningitis  C 1.26 (0.77–2.07);
booster  pneumococcal  1.69  (0.23–12.14);  and primary  5 in 1 1.04  (0.88–1.23).
Discussion:  Findings  suggest  that  children  who  move  home  frequently  are  not  adversely  affected  in  terms
of  the  uptake  of  immunisations  and  whether  they  were  given  within  a speciﬁed  timeframe.  Both  were
high  and may  reﬂect  proactive  behaviour  in  the  primary  healthcare  setting  to  meet Government  coverage
rates  for immunisation.
©  2016  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license. Introduction
The overall aim of routine childhood immunisation is to pro-
ect all children against preventable childhood infections [1,2].
rimary and booster vaccines are offered to all children in the UK
s part of a routine schedule to protect against diphtheria, tetanus,
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pertussis, polio, haemophilus B inﬂuenza, measles, mumps, rubella,
meningitis C and pneumococcal infection amongst other things.
Previous research has shown that children who  experience
frequent childhood house moves have poorer physical and men-
tal health both in child and adulthood, compared with children
who are more residentially stable [3–6]. There have however been
conﬂicting ﬁndings regarding the effect that frequent relocation has
on immunisation uptake. Data from the Millennium Cohort Study
found that children who lived in families which had moved during
pregnancy or more than two  times after the birth of the child were
more likely to be partially immunised with the primary immu-
nisations and unimmunised against measles, mumps  and rubella.
Residential mobility was not associated with not being unimmu-
nised with the primary vaccines, or for the single MMR  vaccine
use [7]. The authors suggested that the decision not to immunise
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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epresents an active decision not to do so by the parents, whilst
artial immunisation may  be more representative of difﬁculties in
etting vaccinations due to higher mobility.
Studies of highly mobile communities in China and India indi-
ate that the immunisation coverage of mobile children was
igniﬁcantly less than of non-mobile children [8,9]. Work in the
K in travelling communities has similarly documented reduced
evel of uptake of immunisations in this mobile community [10].
owever, researchers in Finland have reported that there was no
ssociation between address changes and use of primary care ser-
ices [11].
‘Looked after children’ (deﬁned in the U.K. as being within
he care of the Local Authority Government) have been shown to
e more likely to have an incomplete immunisation record, and
here it is complete, to have received immunisations later than
hose children living in their own homes [12–14]. Parental lifestyle,
ncluding moving home, has been suggested as a possible reason
or non-immunisation [13]. A child exposed to frequent residen-
ial relocation, even if they are not ‘looked after’, may  have similar
n-met health needs.
We carried out an analysis of record linked data on a large
nonymised population based cohort of children born in Wales
etween 1 January 1990 and 31 December 2008 to compare the
ates for routine immunisations, and whether they were up to date
n children who moved home frequently within the ﬁrst year of life
ompared to children who did not move.
. Methods
.1. Data sources
This study used data from the Wales Electronic Cohort for Chil-
ren (WECC) held within the SAIL databank [15]. SAIL is part of the
ational research infrastructure in Wales based at Swansea Univer-
ity, UK and is a relational database capable of linking anonymized
ata at individual and household level across many health and
ealth-related data sets [16]. Phase one of the WECC consists of
inked anonymized records for over 800,000 children born or liv-
ng within Wales between 1 January 1990 and 31 December 2008.
he individual-level anonymized data on these children that were
sed for this study were obtained from numerous sources: the
elsh Demographic Service (WDS), a continually updated record
f children living in Wales; community child health records from
he National Community and Child Health Database (NCCHD); and
irths and deaths from the Ofﬁce for National Statistics (ONS).
The information on individuals is linked together from different
atasets using Anonymised Linking Fields (ALFs) and information
t the household level can be linked together using a similarly
onstructed Residential Anonymised Linking Field (RALF) [17,18].
ALFs are assigned to each child based on their current address
sing the Welsh Demographic Service (WDS) dataset held within
AIL. This is compiled from address changes provided by patients
o their General Practitioner. Some short term residential moves
owever may  not be registered as they rely on the patient noti-
ying their General Practitioner of an address change. This unique
et-up enables longitudinal analyses to be undertaken on data for
roups of individuals living together in the same household, includ-
ng the ability to follow movement between residences over time
19].
.2. Cohort development and compositionWe  collated data on immunisation status electronically from the
CCHD. Children were included in the cohort if they had a week of
irth between 01/01/1990 and 31/12/2008, were born in Wales, had 34 (2016) 1773–1777
an exact match to an NHS number, had a live status at birth and for
whom immunisation data were available. We  excluded stillbirths,
infant deaths and children moving into or out of Wales from our
analysis.
2.3. Measure of exposure
For the purposes of this study, a residential move was  deﬁned
as ‘a change of residence that was  registered with a General Practi-
tioner’. The number of house moves was  calculated using data from
the Welsh Demographic Survey (WDS) linked to the RALFs. In this
analysis we calculated the number of residential moves from the
week of birth until the age the immunisation was  due. For the pri-
mary 5 in 1 vaccine we calculated residential moves up to age 4
months; for primary MMR,  booster Meningitis C and booster pneu-
mococcal vaccines we  calculated residential moves up to age 12
months.
2.4. Measurement of outcome
The outcome measures of interest were uptake of routine immu-
nisations and whether they were given by an agreed timeframe up
to age two. We  pre-deﬁned whether immunisations were delayed
in being given for each immunisation of the standard UK  sched-
ule in consultation with a group of community paediatricians and
according to previous published literature [12] (see Table 1).
3. Statistical analysis
We  analysed the data using SPSS version 19. We  compared chil-
dren who had not moved prior to the relevant immunisation on
time date, to children who  had moved frequently and compared
uptake rate of immunisations and whether they were delayed or
not. We  deﬁned frequent movers as those who  had moved: 2 or
more times in the period prior to the ﬁnal scheduled on-time date
(4 months) for 5 in 1 vaccinations (against diphtheria, tetanus,
pertussis, polio and haemophilus B); and 3 or more times in the
period prior to the ﬁnal scheduled on-time date (12–13 months)
for primary MMR,  booster pneumococcal and booster Meningitis C
vaccinations. Using the child’s week of birth and week of immun-
isation we were able to determine whether immunisations were
received or not for each child and whether they were delayed or
not in being given. We  compared data for uptake of immunisations
and whether they were given by a speciﬁed timeframe between the
non-moving and frequent moving groups. We  calculated univari-
ate odds ratios (95% conﬁdence intervals) to determine if there was
any difference between the non-movers and the frequent movers.
4. Ethical approval
National Research Ethics Service (NRES) guidance does not
require ethical review for anonymised databank studies. We
obtained approval from the independent Information Gover-
nance Review Panel (IGRP), whose membership includes Caldicott
Guardians and other Information Governance professionals, lay
people and representatives from the National Research Ethics
Service (NRES) to use SAIL to answer the speciﬁc house moves
research question [15,16].
5. ResultsAfter accounting for dates for the roll-out programme for a
particular immunisation (see Table 1), the ﬁnal cohort sizes for
analyses were: primary MMR  512,018; primary 5 in 1 vaccine
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Table  1
Routine immunisations with deﬁnitions of speciﬁed timeframes for timeliness.
Primary immunisation Scheduled age Pre-speciﬁed timeframe for immunisation Start of routine electronic data collection
Primary 5 in 1 2–4 months 12 months 1992
Primary MMR 12–13 months 24 months Pre 1990
Booster pneumococcal 12–13 months 24 months 2006
Booster Meningitis C 12–13 months 24 months 1999
Table 2
Routine immunisations received and immunisations by speciﬁed timeframe with increasing frequency of moves.
Frequency of moving house (Age 0 to <12 months old, except 5 in 1a)
0 (n, %) 1 (n, %) 2 (n, %) 3+ (n, %) Total
Immunisation received
Primary MMR  (due at 12–13M)
Yes 439,387 (93.2%) 61,969 (94.0%) 8073 (94.3%) 1502 (93.6%) 510,931
No  32,142 (6.8%) 3949 (6.0%) 489 (5.7%) 102 (6.4%) 36,682
Total  471,529 (100%) 65,918 (100%) 8562 (100%) 1604 (100%) 547,613
Booster Meningitis C (due at 12–13M)
Yes 201,150 (97.5%) 32,009 (98.5%) 4252 (98.1%) 811 (98.4%) 238,222
No  4914 (2.4%) 487 (1.5%) 76 (1.8%) 12 (1.5%) 5489
Total  206,064 (100%) 32,496 (100%) 4328 (100%) 823 (100%) 243,711
Booster pneumococcal (due at 12–13M)
Yes 35,990 (96.7%) 6499 (97.6%) 1008 (97.5%) 187 (97.9%) 43,684
No  1229 (3.3%) 160 (2.4%) 26 (2.5%) 4 (2.1%) 1419
Total  37,219 (100%) 6659 (100%) 1034 (100%) 191 (100%) 45,103
Primary 5 in 1 (due at 4M)b
Yes 454,802 (95.7%) 16,398 (96.4%) 1124 (96.3%) 472,324
No  19,186 (4.0%) 556 (3.3%) 37 (3.2%) 19,779
Total  473,988 16,954 1161 492,103
Immunisation by speciﬁed timeframe
Primary MMR  (1 doses required; by 24M)
Yes 387,383 (87.7%) 53,411 (87.8%) 6847 (88.0%) 1255 (86.7%) 448,896
No  54,561 (12.3%) 7438 (12.2%) 930 (12.0%) 193 (13.3%) 63,122
Total  441,944 (100%) 60,849 (100%) 7777(100%) 1448 (100%) 512,018
Booster Meningitis C (due by 24M)
Yes 171,071 (97.0%) 26,787 (97.9%) 3433 (97.6%) 652 (97.6%) 201,943
No  5279 (3.0%) 587 (2.1%) 83 (2.4%) 16 (2.4%) 5965
Total  176,350 (100%) 27,374 (100%) 3516 (100%) 668 (100%) 207,908
Booster pneumococcal (due by 24M)
Yes 8959 (96.5%) 1777 (97.5%) 265 (96.7%) 46 (97.9%) 11,047
No  325 (3.5%) 46 (2.5%) 9 (3.3%) 1 (2.1%) 381
Total  9284 (100%) 1823 (100%) 274 (100%) 47 (100%) 11,428
Primary 5 in 1 (due by 12M)b
Yes 357,816 (79.9%) 13,060 (83.4%) 865 (83.8%) 371,741
No  90,225 (20.1%) 2596 (16.6%) 167 (16.2%) 92,988
Total  448,041 (100%) 15,656 (100%) 1032 (100%) 464,729
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b Frequent house moves classiﬁed as 2 or more moves as time prior to immunisa
64,756; booster Meningitis C 207,916 and booster pneumococcal
1,428.
Table 2 shows the percentage of children who received the
rimary MMR,  booster Meningitis C, booster pneumococcal and
rimary 5 in 1 immunisations and whether there was any delay
vident with increasing frequency of house moves. The coverage
f the immunisation programme was high across all categories:
MR (>93%), meningitis C (>97%), pneumococcal (>96%) and 5 in
 (>95%). The proportion of children who received their immuni-
ations by the speciﬁed timeframes was also high across all house
oves categories: MMR  (>86%), meningitis C (>97%), pneumococcal
>96%) and 5 in 1 (>79%).
Table 3 shows the comparison of immunisation uptake betweenhe non-moving and frequently moving groups. Moving home fre-
uently did not increase the odds of not being immunised when
ompared to not moving home. Table 4 shows the comparison
f the primary immunisations and whether they were delayednd timeliness of immunisation.
hedule due date only 4 months.
in being given between the non-moving and frequently moving
groups. Again the odds of immunisations being given by the speci-
ﬁed timeframe were not different between the frequently moving
and non-moving groups.
6. Discussion
Our study, which examined the association between frequent
residential moves on uptake rate and whether immunisations were
delayed for the studied routine primary and booster immunisa-
tions scheduled in early childhood in the UK, demonstrated that
frequent home moves do not appear to have a detrimental effect
on immunisation status.We  found no differences between frequent and non-movers
in terms of rate of uptake of the primary and booster immunisa-
tions studied or whether the administration of these was  delayed.
The uptake rate of immunisations and whether they were given
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Table 3
Record of completion for each routine immunisation in frequently moving (3 or greater movesa) and non-moving children.
Immunisation Frequent movers %
complete (number
complete/eligible)
Non-movers % complete
(number complete/eligible)
Difference
(non-movers − frequent
movers)
Odds ratio (95% conﬁdence
intervals)
Primary MMR  93.6 (1502/1604) 93.2 (439,387/471,529) −0.4 1.08 (0.88–1.32)
Booster Meningitis C 98.5 (811/823) 97.6 (201,150/206,064) −0.9 1.65 (0.93–2.92)
Booster Pneumococcal 97.9 (187/191) 96.7 (35,990/37,219) −1.2 1.60 (0.59–4.31)
Primary 5 in 1 96.8 (1124/1161) 96.0 (454,802/473,988) −0.8 1.28 (0.92–1.78)
a Frequently moving deﬁned as 2 or more moves up to 4 months for Primary 5 in 1 vaccine.
Table 4
Record of immunisations by speciﬁed timeframe for each routine immunisation in frequently moving (3 or greater movesa) and non-moving children.
Immunisation Frequent movers % by
speciﬁed timeframe
(number by speciﬁed
date/eligible)
Non-movers % by speciﬁed
timeframe (number by
speciﬁed date/eligible)
Difference
(non-movers − frequent
movers)
Odds ratio (95% conﬁdence
intervals)
Primary MMR  86.7 (1255/1448) 87.7 (387,383/441,944) 1.0 0.92 (0.79–1.07)
Booster Meningitis C 97.6 (652/668) 97.0 (171,071/176,350) −0.6 1.28 (0.77–2.07)
Booster Pneumococcal 97.9 (46/47) 96.5 (8959/9284) −1.4 1.69 (0.23–12.14)
/448,0
 1 vac
b
g
c
n
i
c
t
t
r
c
e
ﬁ
i
a
p
w
p
m
s
t
w
w
p
v
s
t
t
[
i
(
n
b
n
n
d
f
c
c
d
f
TPrimary 5 in 1 83.8 (865/1032) 80.0 (357,816
a Frequently moving deﬁned as 2 or more moves up to 4 months for Primary 5 in
y the speciﬁed timeframe was high across all house moves cate-
ories. Findings from the Millennium Cohort Study, suggested that
hildren from families that moved more frequently or during preg-
ancy were more likely to be partially immunised with primary
mmunisations and unimmunised against MMR  [7]. The authors
oncede that reasons for non-immunisation of children are likely
o be based on parental choice not to immunise, whereas par-
ial immunisation is more likely to be due to practical difﬁculties
elated to residential mobility. Although we did not examine the
ompleteness of the full immunisation programme, instead only
xamining selected parts, our ﬁndings do however agree with the
ndings from the Millennium Cohort Study in relation to primary
mmunisations, where frequent residential moves did not result in
ny change in immunisation uptake rate [7].
Research has suggested that reasons for non-immunisation or
artial immunisation may  be related to parental lifestyle factors
hich includes frequent residential mobility, family size and lone
arent status [13,20–22]. Findings from other countries and highly
obile travelling communities have also suggested that the rea-
on mobile children had poor immunisation rates were because of
heir limited access to health services [8–10]. Only those children
hose parents have registered them with a healthcare provider
ere included in our cohort. It is likely therefore that our study
opulation still has good access to and utilisation of health ser-
ices despite moving frequently. The Department of Health has
et national targets for immunisation rates with the aim that by
he age of two, 95% of children will be immunised against diph-
heria, tetanus, polio, pertussis, Hib, measles, mumps  and rubella
23]. In addition, general practitioners are now incentivised to reach
mmunisation targets by the Quality and Outcomes Framework
QOF) [24]. The lack of correlation seen in our study could be due to a
umber of reasons. The immunisation uptake rate within Wales has
een high for a number of years and could demonstrate the robust-
ess of the vaccination program within Wales (http://www.wales.
hs.uk/sites3/page.cfm?orgid=457&pid=54144), thereby making it
ifﬁcult to detect any differences. It may  also be that Wales has dif-
ering socio-demographic factors or social support systems when
ompared to other geographical areas resulting in a decreased asso-
iation between social stress and residential mobility; or it may  be
ue to our study design. These issues require further exploration in
uture studies.
We conducted this study using a large retrospective data cohort.
here are strengths and limitations with this methodology. One41) −3.8 1.04 (0.88–1.23)
cine.
strength of our study was  that the size of the cohort with a large
sample size for all the outcomes of interest. In addition, many of
the outcomes were collected in a standardised way and as such
this allowed a more rigorous comparison of the data.
In our study, a residential move was  deﬁned as the change of
address registered with the General Practitioner. It was recognised
that a move may  only be next door or to any location within Wales.
It was  noted that some short term residential moves may  not be reg-
istered and would therefore not be captured as they relied on the
families notifying their health care providers when their address
changed. This was recognised as a limitation of the study. The
frequency of residential moves in our study is therefore likely to
be under reported. In addition, our study did not examine details
regarding the distance of the move. For the purposes of our analysis,
only the frequency of moves in our pre-speciﬁed periods was  exam-
ined. The timing of the moves was  not examined in our models. It
is possible that unregistered children may  not be detected as not
being immunised or under-immunised or delayed. It is also likely
that unregistered children are more likely to be under vaccinated
due to decreased health seeking behaviour. Findings from the Mil-
lennium Cohort Study have indicated that high residential mobility
resulted in increased likelihood of non-response to their survey
[25]. Although we used different methods and data sources, it is
still possible that this had an effect on our ﬁndings. Finding alter-
native ways to identify these children may  ameliorate this problem,
but would be difﬁcult within the context of this anonymised cohort
study.
Our deﬁnitions of whether the vaccinations were delayed or
not in being given also may  not be as sensitive when compared to
other previously used deﬁnitions of timeliness [26–29] and were
based largely on clinical discussions. This may  have resulted in an
overestimation of the number of children protected from infec-
tious diseases through immunisation given that even a small delay
will make some children vulnerable and could impact on herd
immunity in the general population [26]. We  recommend further
research employing more stringent deﬁnitions of timeliness within
our cohort to determine whether this would have any impact on
our ﬁndings.Funding source
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